{
  "title": "CVS and Walgreens Near $10 Billion Deal to Settle Opioid Cases",
  "link": "https://www.nytimes.com/2022/11/02/health/cvs-walgreens-opioids-settlement.html",
  "guid": "https://www.nytimes.com/2022/11/02/health/cvs-walgreens-opioids-settlement.html",
  "atom:link": "",
  "description": "The dual agreements would resolve thousands of lawsuits over the retailersâ€™ role in the addiction crisis. But a large majority of state, local and tribal governments must sign on.",
  "dc:creator": "Jan Hoffman",
  "pubDate": "Wed, 02 Nov 2022 21:46:14 +0000",
  "category": [
    "CVS Caremark Corporation",
    "Walgreen Co",
    "Drugstores",
    "Suits and Litigation (Civil)",
    "Compensation for Damages (Law)",
    "Opioids and Opiates",
    "Pain-Relieving Drugs",
    "Drugs (Pharmaceuticals)",
    "States (US)",
    "Native Americans",
    "your-feed-healthcare",
    "your-feed-science"
  ],
  "media:content": "",
  "media:credit": "Jeenah Moon for The New York Times",
  "media:description": "CVS said that over the next 10 years, it would pay $4.9 billion to states and municipal governments and approximately $130 million to tribes."
}